TB-SEQ, Inc. is a life-science company devoted to the development and application of experimental and computational procedures for functional (meta)genomics analysis of prokaryotic and eukaryotic organisms and communities based on the ribosome profiling NGS platform technology (RIBO-seq) and on computational analysis of sequencing data. TB-Seq develops new experimental protocols and bioinformatics tools applicable to different biological system, and offers related services. Our team combines decades of experience in research and development in computational sequence analysis, molecular biology and biochemistry, in experimental analysis of nucleic acids, and in protein and nucleic acid sequence and structure computational analysis. Our proprietary optimized RIBO-seq protocols allow us to produce RIBO-seq libraries of the highest quality more efficiently and with enhanced sensitivity compared to competing protocols. We have the computational capabilities to perform customized analyses on your sequencing data, using available software packages, our suite of bioinformatics tools, or by developing new analytical tools according to your needs. Whatever the information you are looking to extract from your data, we will be happy to discuss with you the most appropriate computational-analysis design, and to execute it for you. TB-SEQ Bioinformatics offers high-end robust bioinformatics to optimize analysis of the information provided by microbiome studies using the most highly rated software packages for all bioinformatics analyses, as well as proprietary software developed by TB-SEQ scientists. Our team has combined decades of experience in scientific research and can assist you in creating a robust and effective experimental design in relation to your samples, your scientific/development goals, and your budget.
| Website | http://www.tbseq.com |
| Revenue | $5 million |
| Employees | 3 (2 on RocketReach) |
| Founded | 2015 |
| Address | 458 Carlton Ct Ste H, South San Francisco, California 94080, US |
| Phone | +1 650-865-8064 |
| Technologies |
JavaScript
,
HTML
,
Google Maps
+4 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Functional Genomics, Ngs Data Analysis, Microbial Genomics, Genomic Sequencing, Bioinformatics, Rna Sequencing, Transcriptomics, High Throughput Sequencing, Next Generation Sequencing, Biological Data Analysis, Genomic Research, Life Science Research, Data Science |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, Oxford Nanopore Technologies, PacBio, BGI Genomics, MGI Tech Co. +41 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular TB-SEQ, Inc. employee's phone or email?
The TB-SEQ, Inc. annual revenue was $5 million in 2026.
Luciano Brocchieri is the CEO and Director of Bioinformatics of TB-SEQ, Inc..
2 people are employed at TB-SEQ, Inc..
TB-SEQ, Inc. is based in South San Francisco, California.
The NAICS codes for TB-SEQ, Inc. are [541713, 54171, 54, 541, 5417].
The SIC codes for TB-SEQ, Inc. are [873, 87].